• Bhubaneswar India
  • Contact+ 91-9938772605
  • Mon - Sat : 10:00AM - 6:00PM

Tag: profit

Panasonic Energy India Maintains Profit Growth in Q2 FY2024-25

New Delhi, November 8, 2024: Panasonic Energy India Co. Ltd. (PECIN) a part of Panasonic Holdings Corporation today announced its financial results for the quarter ending September 30, 2024. In the Q2 FY2024-25, the company recorded a modest increase in revenue from operations to INR 686.4 million, a 0.42% year-over-year rise compared to INR 683.5 million in Q2 FY2023-24. Despite the modest revenue growth, the company’s profit after tax (PAT) witnessed growth, rising 17.39% to INR 38.81 million. The company posted a growth of 12.72% on EBITDA margins signifying a strong balance sheet with a market cap of INR 3667.13 million.

For the first half (H1 FY2024-25), PECIN demonstrated strong profit growth despite a 9.33% decline in revenue from operations, which totaled INR 1,316 million. The dip in revenue was primarily due to additional sale to the Election Commission in the first half of FY2023-24, which contributed approximately 11.4% to that period’s revenue. Excluding the impact of this one-time sale, however, the company achieved a 2% increase in overall sales in H1 FY2024-25, underscoring a strong underlying demand. The PAT for the first half of the current fiscal year reported a robust growth of 35%, increasing to INR 81.82 million from INR 60.52 million last year.

While announcing the results, Mr. Akinori Isomura, Chairman and Managing Director Panasonic Energy India Co. Ltd. (PECIN) said, “The strong profitability underscores our commitment to operational excellence and adaptability in dynamic market conditions. Driven by the company’s strategic focus on cost optimization, especially in materials amid declining zinc prices, we remain focused on enhancing stakeholder value and building momentum for sustained growth in the quarters ahead.

He added, “We have several strategic initiatives underway to support our growth trajectory. These include expanding our reach in the rapidly growing rural markets, capturing our market share in high-potential areas, enhancing brand recognition, and increasing the share of premium products in our sales mix. With these, we are confident to further solidify our performance and market competitiveness.

The PECIN factory in Pithampur (Madhya Pradesh) is a Carbon Neutral Factory and has received a Certificate of Verification Carbon Unit (VCU) Retirement from Verra. Additionally, it has been certified by the International REC Standard. The wastewater treatment at the factory results in zero discharge of wastewater and furthermore, 50% of factory land has a forest cultivated by PECIN. In the view of further Co2 reduction company is expanding the installed solar capacity to ensure 30% solar coverage up from current 19%. At present, company uses approximately 6% recycled materials in their products which is in-line to the direction of 3R (Reduce, Reuse Recycle). The company is committed to invest more on plantation of trees for the 2nd year under its Corporate Social Responsibility initiatives in line with Schedule VII of the Companies Act, 2013.

On manufacturing front, PECIN aims for better quality of human life and preservation of the planet. Majority of the products manufactured by the Company are eco-friendly in nature with no addition of (Mercury) Hg, (Cadmium) Cd, (Lead) Pb. Company’s manufactured products are compliant with the limits set by RoHS Directives (EU) 2015/863. Currently, the product portfolio is around 87% zinc carbon batteries and 5% alkaline batteries, 5% rechargeable batteries, and 3% Lithium coin batteries.

Alembic Pharma Sees 12% Increase in Q2FY25 Profit, Touching Rs. 153 Crores

7th November 2024, Mumbai: Alembic Pharmaceuticals Limited reported its consolidated financial results for the second quarter ended 30th September 2024.

Mr. Shaunak Amin, MD, Alembic Pharmaceuticals Limited said “India’s Branded Business continues to enhance execution capabilities in both quality and scale, with the Specialty and Animal Health segments showing good growth. The USFDA successfully inspected our Oncology Formulation Facility (F-2) without any form 483 observations.”

India Branded Business

  • India Branded Business grew 6% to Rs. 609 Crores for the quarter.
  • Recorded good growths in specialty therapies like 8% in Gynaecology, 11% in Cardiology, 18% in Anti Diabetic and 13% in Ophthalmology therapies.
  • Animal Health business grew 20% for the quarter with basket of strong brands driving outperformance.
  • 3 launches during the quarter. New launches continue to do well along with promising future launches across key segments.

International Business

Particulars Q2 FY25 Q2 FY24 % Change H-1 FY25 H-1 FY24 % Change
Formulation            
  India 609 577 6% 1181 1101 7%
  USA

Ex- US

467

298

444

252

5%

18%

928

568

834

518

11%

10%

API 274 322 (15%) 532 628 (15%)
Total 1648 1595 3% 3210 3081 4%

Apollo Hospitals Enterprise Ltd. Q2FY25 Result First Cut – Net profit soars on healthcare services demand

views of Apollo Hospitals Enterprise LtdQ2FY25 Result by Prathamesh Masdekar, Research Analyst, StoxBox

 – Apollo Hospitals Enterprise Ltd. reported robust performance in Q2FY25, with an increase in EBITDA and PAT margins.

– Consolidated Revenue from Operations stood at Rs. 5,589 crores in Q2FY25, up 15.3% YoY / up 9.9% QoQ. The revenue driven by higher demand for its healthcare service

– EBITDA increased 30.0% YoY / up 20.8% QoQ to Rs. 816 crores, while EBITDA margin stood at 14.6% (up 164bps YoY / up 132bps QoQ) in Q2FY25, led by an expansion in gross margins by 45bps QoQ to 48.9%.

– The Profit after Tax stood at Rs. 396 crores (up 59.0% YoY / up 25.4% QoQ) in Q2FY25, above market expectations of Rs. 367 crores. The PAT margin rose to 7.1% versus 6.2% in Q2FY24.

– The company’s digital health and pharmacy vertical, which offers online consultations and operates the ‘Apollo 24/7′ platform, reported a profit of 389 mn rupees, compared with a loss a year ago, further boosting the hospital chain operator’s margins.

– Apollo Hospitals had 7,994 operating beds across the network (excluding AHLL & managed beds), out of which 2,557 were new. The overall occupancy for hospitals was at 73% vs 68% in the same period in the previous year, aided by a strong increase in patient flows across hospitals.

– Apollo Hospitals announced the expansion of its existing hospital facility in Lucknow to 500 beds from the present 300 beds by adding another 200 beds, to be developed on their recent acquisition of a 1.2-acre land.

– The Government signed an MoU with Apollo Hospitals to provide free treatment for children with heart disease, as announced by the Tripura Chief Minister.

– Apollo Hospitals continues to boost medical tourism, strengthening its global position as a healthcare destination for advanced treatments.

BPCL Ltd. Q2FY25 Result First Cut – Profit dipped due to weakening margins

– BPCL reported a consolidated revenue growth of 1.1% YoY / down 7.9% QoQ to Rs. 1,17,949 crores, missing the street estimates.
– EBITDA decreased 65.1% YoY / down 19.7% QoQ to Rs. 4,517 crores, while EBITDA margin stood at 3.8% (down 726 bps YoY / down 56 bps QoQ) in Q2FY25.
– Profit after Tax declined 72% YoY / down 19% QoQ to Rs. 2,297 crores in Q2FY25. PAT margin came at 1.9% versus 2.2% in the previous quarter.
– The refinery data during the quarter declined marginally to 10.28 MMT, compared with 9.35 MMT in the last quarter.
– The market sales of the company for Q2FY25 grew 1.6% to 12.39 million metric tonnes compared to 12.19 million metric tonnes for Q2FY24.

Views by Akriti Mehrotra, Research Analyst, StoxBox:
Oil refining giant Bharat Petroleum Corp. Ltd. reported weak operational performance annually in Q2FY25 due to lower marketing margins and adverse weather conditions impacting agricultural demand. The average gross refining margin (GRM) fell to $6.12/barrel in H1FY25, down from $15.42/barrel in the same period last year. While improved marketing margins and a rebound in GRM could enhance future performance. With a decline in fuel consumption and falling global crude oil prices, we will closely monitor any government actions that could affect the company’s financial performance in the short to medium term.

Q2 FY25 Highlights: YES BANK Achieves 145% YoY Increase in Net Profit to Rs 553 Crore

New Delhi, October 28, 2024: YES BANK, India’s sixth largest private sector bank announced its Q2FY25 results with a notable 145.6% YoY increase in Net Profit to INR 553 crore, alongside a 10.1% QoQ growth. The Bank’s Operating Profit rose to INR 975 crore, marking a 21.7% YoY and 10.2% QoQ increase. Net Interest Income (NII) stood at INR 2,200 crore, up 14.3% YoY, with stable Net Interest Margin (NIM) at 2.4%, and Non-Interest Income rose to INR 1,407 crore, achieving a 16.3% YoY and 17.3% QoQ growth. Despite a 12.8% YoY rise in Operating Expenses, the Cost-to-Income Ratio improved to 73.0%. The balance sheet shows sustained momentum, with deposits growing 18.3% year-over-year (y-o-y) and 4.6% quarter-over-quarter (q-o-q), and a CASA ratio up to 32.0%, increasing by 260 basis points y-o-y. Net advances grew 12.4% y-o-y, led by strong gains in SME (25.8%), mid-corporate (25.5%), and corporate advances (21.8% y-o-y and 4.6% q-o-q), while retail advances remained flat to focus on profitability. Additionally, there was no priority sector lending (PSL) shortfall for Q2FY25, achieved through increased organic balances and PSLC purchases.

Asset quality improved, with the GNPA ratio falling to 1.6% from 2.0% y-o-y and the Provision Coverage Ratio (PCR) rising to 70.0%. The balance sheet grew 14.5% y-o-y, with CD Ratio at 84.8% v/s 89.2% in Q2FY24 and 86.6% in Q1FY25. Net advances rose 12.4% y-o-y, fuelled by strong growth in SME, mid-corporate, and corporate advances, while retail advances held steady to support profitability goals. The combined metric of Net NPA and net carrying value of security receipts as a percentage of advances more than halved on a y-o-y basis, reaching 0.9% in Q2FY25, while remaining stable q-o-q. The NPA Provision Coverage Ratio (PCR) also improved significantly to 70.0%, up from 56.4% in Q2FY24 and 67.6% in Q1FY25. Recovery and resolution momentum held strong, achieving INR 1,021 crore in Q2FY25. Standard restructured accounts fell to INR 2,125 crore (0.9% of advances), down from 2.2% in Q2FY24 and 1.6% in Q1FY25, driven by ongoing resolutions and upgrades.

Commenting on the results and financial performance, Mr. Prashant Kumar, Managing Director & CEO, YES BANK said, “Our Q2FY25 performance has been encouraging, especially if seen in the context of industry headwinds. The Deposit momentum has been maintained with 18% y-o-y growth, along with a healthy CASA ratio (now at 32%) expansion on both y-o-y & q-o-q basis, on the back of CA growth at 26% y-o-y & 11% q-o-q and SA growth at 30% y-o-y & 7% q-o-q. At same time, the slippage ratio (at 2.2% of Advances) remains range-bound within the guidance range. Other Asset Quality parameters such as GNPA ratio, PCR and O/S Restructured loans have all improved on q-o-q basis.

The Bank continues to deliver as per the stated strategic objectives, with superior growth in SME and Mid Corporate segments, growth resumption in the Corporate segment and calibration of growth in Retail segment, aimed at profitability improvement. Bank also continues to maintain NIL PSL shortfalls.

These along with other drivers have enabled the Bank to deliver healthy Operating Profit and Net Profit growth. The RoA of the Bank has been consistently at 0.5% over last 3 quarters. The Bank has also strengthened its management team with key senior hires in Retail Assets and Financial Markets Team. We have received external validation in the form of Credit Rating upgrades over the last 2 quarters. While we navigate the challenges in the operating environment, we remain confident of our progress towards building a franchise which delivers superior returns to our stakeholders.”